| (210) | Number of the EPO application | 17725143 |
| (220) | Filing date of the EPO application | 2017.05.15 |
| (80) | EPO patent specification publication (B) | EPB nr. 14/2020, 2020.04.01 |
| (110) | EPO patent number | 3458084 |
| (21) | Number of the application | e 2019 0355 |
| (71) | Name(s) of applicant(s), code of the country | Intarcia Therapeutics, Inc, US; |
| (72) | Name(s) of inventor(s), code of the country | BLACKWELL William, US;
SRIVASTAVA Ved P., US;
PAULIK Mark A., US;
YOUNG Andrew, US;
DOCK Steven Thomas, US;
HUNTER III Robert Neil, US; |
| (73) | Name(s) of owner(s), code of the country | INTARCIA Therapeutics Inc, US; |
| (54) | Title of the invention | GLUCAGON-RECEPTOR SELECTIVE POLYPEPTIDES AND METHODS OF USE THEREOF |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 38/26 (2006.01.01); C07K 14/605 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2019.04.30 |
| (30) | Priority | 201662337005 P, 2016.05.16, US; 201662414146 P, 2016.10.28, US; 201662420937 P, 2016.11.11, US |
| (86) | International application | PCT/US2017/032714, 2017.05.15 |
| (87) | International publication | WO 2017/200943, 2017.11.23 |